Status:
COMPLETED
Circulating Tumour Cells in Patients With Peritoneal Metastases
Lead Sponsor:
Uppsala University
Conditions:
Circulating Tumor Cell
Peritoneal Metastases
Eligibility:
All Genders
18-80 years
Brief Summary
This study aims to evaluate the prognostic value of circulating tumour cells (CTC) in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy due to gastrointestinal ca...
Detailed Description
CTCs har extracted by way of a new method at baseline, during surgery, and postoperatively. The occurence of such CTCs will be investigated for prognostic evaluation. Patients will be follow-up by Cli...
Eligibility Criteria
Inclusion
- Peritoneal metastases being treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Exclusion
- None
Key Trial Info
Start Date :
October 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04083547
Start Date
October 17 2017
End Date
November 1 2020
Last Update
November 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akademiska Sjukhuset (Uppsala University hospital)
Uppsala, Sweden, 75185